The anti-histamine azelastine, identi ed by computational drug repurposing, inhibits infection by major variants of sars-cov-2 in cell cultures and reconstituted human nasal tissue

HIGHLIGHTS

• who: The Anti-Histamine Azelastine et al. from the Chinese Academy College, China University California, San Francisco have published the research work: The Anti-Histamine Azelastine, Identi ed by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue, in the Journal: (JOURNAL)
• what: Most importantly, the authors provide evidence that the histamine 1 (H1) receptor blocker azelastine, widely used in allergic rhinitis therapy in a nasal spray formulation, is effective against SARS-CoV-2 infection in several in_vitro assays. The major focus has been . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.